Engineering targeted nanomedicines for advanced prostate cancer

Prostate cancer is one of the most common types of cancer. Prostate cancer treatment protocols include the use of androgen deprivation therapy (ADT) and docetaxel which have high resistance rate in advanced disease stages. XD19 is a novel compound showed a promising activity on C4-2B prostate cancer...

Full description

Bibliographic Details
Main Author: Bahlool, Ahmad
Other Authors: Κλεπετσάνης, Παύλος
Format: Thesis
Language:English
Published: 2020
Subjects:
Online Access:http://hdl.handle.net/10889/13586